• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Successful generation of primary virus-specific and anti-tumor T-cell responses from the naive donor T-cell repertoire is determined by the balance between antigen-specific precursor T cells and regulatory T cells.成功地从幼稚供体 T 细胞库中产生针对原发性病毒和肿瘤的 T 细胞反应,取决于抗原特异性前体 T 细胞和调节性 T 细胞之间的平衡。
Haematologica. 2011 Aug;96(8):1204-12. doi: 10.3324/haematol.2010.039099. Epub 2011 May 5.
2
Alloreactive and leukemia-reactive T cells are preferentially derived from naive precursors in healthy donors: implications for immunotherapy with memory T cells.同种反应性和白血病反应性 T 细胞优先从健康供体中的幼稚前体中衍生而来:对记忆 T 细胞免疫治疗的影响。
Haematologica. 2011 Jul;96(7):1024-32. doi: 10.3324/haematol.2010.037481. Epub 2011 Apr 12.
3
Selective depletion of alloreactive T lymphocytes using patient-derived nonhematopoietic stimulator cells in allograft engineering.在同种异体移植工程中,使用患者来源的非造血刺激细胞选择性清除同种异体反应性T淋巴细胞。
Transplantation. 2008 Nov 27;86(10):1427-35. doi: 10.1097/TP.0b013e31818810d6.
4
Antiviral immunity and T-regulatory cell function are retained after selective alloreactive T-cell depletion in both the HLA-identical and HLA-mismatched settings.在 HLA 相同和 HLA 不匹配的情况下,选择性去除同种异体反应性 T 细胞后,抗病毒免疫和 T 调节细胞功能得以保留。
Biol Blood Marrow Transplant. 2004 Apr;10(4):259-68. doi: 10.1016/j.bbmt.2003.12.001.
5
Optimization of methodology for production of CD25/CD71 allodepleted donor T cells for clinical use.优化用于临床应用的 CD25/CD71 同种异体去除供者 T 细胞的生产方法。
Cytotherapy. 2013 Jan;15(1):109-21. doi: 10.1016/j.jcyt.2012.10.007.
6
In vitro methods for generating CD8+ T-cell clones for immunotherapy from the naïve repertoire.从初始库中生成用于免疫治疗的CD8 + T细胞克隆的体外方法。
J Immunol Methods. 2006 Mar 20;310(1-2):40-52. doi: 10.1016/j.jim.2005.11.023. Epub 2006 Jan 26.
7
Robust Identification of Suitable T-Cell Subsets for Personalized CMV-Specific T-Cell Immunotherapy Using CD45RA and CD62L Microbeads.使用 CD45RA 和 CD62L 微珠对个体化 CMV 特异性 T 细胞免疫治疗进行合适的 T 细胞亚群的稳健鉴定。
Int J Mol Sci. 2019 Mar 20;20(6):1415. doi: 10.3390/ijms20061415.
8
Antigen presentation and immune regulatory capacity of immature and mature-enriched antigen presenting (dendritic) cells derived from human bone marrow.源自人骨髓的未成熟和成熟富集抗原呈递(树突状)细胞的抗原呈递及免疫调节能力
Hum Immunol. 2004 Feb;65(2):93-103. doi: 10.1016/j.humimm.2003.11.002.
9
The simultaneous isolation of multiple high and low frequent T-cell populations from donor peripheral blood mononuclear cells using the major histocompatibility complex I-Streptamer isolation technology.利用主要组织相容性复合体 I-Streptamer 分离技术从供体外周血单核细胞中同时分离多个高亲和性和低亲和性 T 细胞群体。
Cytotherapy. 2018 Apr;20(4):543-555. doi: 10.1016/j.jcyt.2018.01.008. Epub 2018 Feb 12.
10
HA-1H T-Cell Receptor Gene Transfer to Redirect Virus-Specific T Cells for Treatment of Hematological Malignancies After Allogeneic Stem Cell Transplantation: A Phase 1 Clinical Study.HA-1H T 细胞受体基因转导重定向病毒特异性 T 细胞用于异基因干细胞移植后血液系统恶性肿瘤的治疗:一项 1 期临床研究。
Front Immunol. 2020 Aug 20;11:1804. doi: 10.3389/fimmu.2020.01804. eCollection 2020.

引用本文的文献

1
Perspectives of tumor-infiltrating lymphocyte treatment in solid tumors.实体瘤中肿瘤浸润淋巴细胞治疗的观点。
BMC Med. 2021 Jun 11;19(1):140. doi: 10.1186/s12916-021-02006-4.
2
TCR/BCR dual-expressing cells and their associated public BCR clonotype are not enriched in type 1 diabetes.TCR/BCR 双表达细胞及其相关公共 BCR 克隆型在 1 型糖尿病中并不富集。
Cell. 2021 Feb 4;184(3):827-839.e14. doi: 10.1016/j.cell.2020.11.035.
3
Long-term in vitro persistence of magnetic properties after magnetic bead-based cell separation of T cells.基于磁珠的 T 细胞分离后,细胞的磁性在体外长期持续。
Scand J Immunol. 2020 Sep;92(3):e12924. doi: 10.1111/sji.12924. Epub 2020 Jul 17.
4
The allogeneic HLA-DP-restricted T-cell repertoire provoked by allogeneic dendritic cells contains T cells that show restricted recognition of hematopoietic cells including primary malignant cells.同种异体树突状细胞引发的同种异体 HLA-DP 限制性 T 细胞库包含了 T 细胞,这些 T 细胞对包括原发性恶性细胞在内的造血细胞具有受限的识别能力。
Haematologica. 2019 Jan;104(1):197-206. doi: 10.3324/haematol.2018.193680. Epub 2018 Sep 20.
5
Cytomegalovirus induces HLA-class-II-restricted alloreactivity in an acute myeloid leukemia cell line.巨细胞病毒在急性髓系白血病细胞系中诱导HLA-II类分子限制性同种异体反应性。
PLoS One. 2018 Jan 29;13(1):e0191482. doi: 10.1371/journal.pone.0191482. eCollection 2018.
6
HLA-DPB1 mismatch alleles represent powerful leukemia rejection antigens in CD4 T-cell immunotherapy after allogeneic stem-cell transplantation.HLA-DPB1 错配等位基因是异基因造血干细胞移植后 CD4 T 细胞免疫治疗中强有力的白血病排斥抗原。
Leukemia. 2017 Feb;31(2):434-445. doi: 10.1038/leu.2016.210. Epub 2016 Aug 1.
7
Generation of memory T cells for adoptive transfer using clinical-grade anti-CD62L magnetic beads.使用临床级抗CD62L磁珠生成用于过继性转移的记忆性T细胞。
Bone Marrow Transplant. 2015 Oct;50(10):1358-64. doi: 10.1038/bmt.2015.135. Epub 2015 Jun 15.
8
Immunotherapy for viral and fungal infections.针对病毒和真菌感染的免疫疗法。
Bone Marrow Transplant. 2015 Jun;50 Suppl 2:S51-4. doi: 10.1038/bmt.2015.96.
9
The coming of age of adoptive T-cell therapy for viral infection after stem cell transplantation.干细胞移植后针对病毒感染的过继性T细胞疗法的成熟
Ann Transl Med. 2015 Apr;3(5):62. doi: 10.3978/j.issn.2305-5839.2015.01.18.
10
CMV-specific T cells generated from naïve T cells recognize atypical epitopes and may be protective in vivo.从初始T细胞产生的巨细胞病毒特异性T细胞识别非典型表位,并且在体内可能具有保护作用。
Sci Transl Med. 2015 Apr 29;7(285):285ra63. doi: 10.1126/scitranslmed.aaa2546.

本文引用的文献

1
Different proliferative potential and migratory characteristics of human CD4+ regulatory T cells that express either CD45RA or CD45RO.表达 CD45RA 或 CD45RO 的人 CD4+ 调节性 T 细胞具有不同的增殖潜能和迁移特性。
J Immunol. 2010 Apr 15;184(8):4317-26. doi: 10.4049/jimmunol.0903781. Epub 2010 Mar 15.
2
Leukemia-associated minor histocompatibility antigen discovery using T-cell clones isolated by in vitro stimulation of naive CD8+ T cells.应用体外刺激初始 CD8+ T 细胞分离 T 细胞克隆发现与白血病相关的次要组织相容性抗原。
Blood. 2010 Jun 10;115(23):4923-33. doi: 10.1182/blood-2009-12-260539. Epub 2010 Mar 4.
3
Enumeration of human antigen-specific naive CD8+ T cells reveals conserved precursor frequencies.枚举人类抗原特异性幼稚 CD8+ T 细胞揭示了保守的前体频率。
Blood. 2010 May 6;115(18):3718-25. doi: 10.1182/blood-2009-10-251124. Epub 2010 Mar 3.
4
NCI First International Workshop on The Biology, Prevention, and Treatment of Relapse After Allogeneic Hematopoietic Stem Cell Transplantation: Report from the Committee on the Biology Underlying Recurrence of Malignant Disease following Allogeneic HSCT: Graft-versus-Tumor/Leukemia Reaction.NCI 首次同种异体造血干细胞移植后复发的生物学、预防和治疗国际研讨会:来自同种异体 HSCT 后恶性疾病复发的生物学基础研究委员会的报告:移植物抗白血病/肿瘤反应。
Biol Blood Marrow Transplant. 2010 May;16(5):565-86. doi: 10.1016/j.bbmt.2010.02.005. Epub 2010 Feb 10.
5
Co-ordinated isolation of CD8(+) and CD4(+) T cells recognizing a broad repertoire of cytomegalovirus pp65 and IE1 epitopes for highly specific adoptive immunotherapy.协调分离识别巨细胞病毒 pp65 和 IE1 表位广泛 repertoire 的 CD8(+) 和 CD4(+) T 细胞,用于高度特异性的过继免疫治疗。
Cytotherapy. 2010 Nov;12(7):933-44. doi: 10.3109/14653240903505822.
6
Functionally active virus-specific T cells that target CMV, adenovirus, and EBV can be expanded from naive T-cell populations in cord blood and will target a range of viral epitopes.能够靶向巨细胞病毒、腺病毒和EB病毒的功能活跃的病毒特异性T细胞,可以从脐血中的初始T细胞群体中扩增出来,并且能够靶向一系列病毒表位。
Blood. 2009 Aug 27;114(9):1958-67. doi: 10.1182/blood-2009-03-213256. Epub 2009 May 14.
7
Differential responsiveness to IL-2, IL-7, and IL-15 common receptor gamma chain cytokines by antigen-specific peripheral blood naive or memory cytotoxic CD8+ T cells from healthy donors and melanoma patients.健康供体和黑色素瘤患者的抗原特异性外周血初始或记忆性细胞毒性CD8+T细胞对IL-2、IL-7和IL-15共同受体γ链细胞因子的差异反应性。
J Immunother. 2009 Apr;32(3):252-61. doi: 10.1097/CJI.0b013e3181998e03.
8
Graft-versus-leukemia effects of transplantation and donor lymphocytes.移植及供体淋巴细胞的移植物抗白血病效应
Blood. 2008 Dec 1;112(12):4371-83. doi: 10.1182/blood-2008-03-077974.
9
Rapid identification and sorting of viable virus-reactive CD4(+) and CD8(+) T cells based on antigen-triggered CD137 expression.基于抗原触发的CD137表达对存活的病毒反应性CD4(+)和CD8(+) T细胞进行快速鉴定和分选。
J Immunol Methods. 2008 Nov 30;339(1):23-37. doi: 10.1016/j.jim.2008.07.017. Epub 2008 Aug 27.
10
Clinical grade generation of hexon-specific T cells for adoptive T-cell transfer as a treatment of adenovirus infection after allogeneic stem cell transplantation.用于过继性T细胞转移的六邻体特异性T细胞的临床级生成,作为异基因干细胞移植后腺病毒感染的一种治疗方法。
J Immunother. 2008 Feb-Mar;31(2):199-206. doi: 10.1097/CJI.0b013e31815ef862.

成功地从幼稚供体 T 细胞库中产生针对原发性病毒和肿瘤的 T 细胞反应,取决于抗原特异性前体 T 细胞和调节性 T 细胞之间的平衡。

Successful generation of primary virus-specific and anti-tumor T-cell responses from the naive donor T-cell repertoire is determined by the balance between antigen-specific precursor T cells and regulatory T cells.

机构信息

Dept. of Hematology, Leiden University Medical Center, Leiden, The Netherlands.

出版信息

Haematologica. 2011 Aug;96(8):1204-12. doi: 10.3324/haematol.2010.039099. Epub 2011 May 5.

DOI:10.3324/haematol.2010.039099
PMID:21546501
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3148915/
Abstract

BACKGROUND

One of the major challenges in allogeneic stem cell transplantation is to find a balance between the harmful induction of graft-versus-host disease and the beneficial graft-versus-leukemia and pathogen-specific immune responses. Adoptive transfer of in-vitro generated donor T cells with specific anti-leukemic or pathogen-specific activity may be effective. However, in many cases this requires the in-vitro priming and expansion of antigen-specific precursor T cells from the naïve donor T-cell repertoire.

DESIGN AND METHODS

Antigen-specific CD8 T cells were generated by co-culture of CD45RO-depleted, regulatory T cell-depleted donor peripheral blood mononuclear cells with autologous peptide-loaded dendritic cells, followed by two re-stimulations with peptide-loaded autologous monocytes. Responding T cells were isolated based on CD137 expression and further purified using peptide/major histocompatibility complex tetramers.

RESULTS

Using this method we were able to reproducibly generate functionally high avidity T cells directed against multiple viral antigens and minor histocompatibility antigens from the naïve T-cell repertoire of seronegative, minor histocompatibility antigen-negative donors. Furthermore, we demonstrated that reduction of the regulatory T-cell frequency by depletion of CD45RO(+) responder cells resulted in improved priming and expansion of antigen-specific precursor T cells.

CONCLUSIONS

In conclusion, we present a robust method for the in-vitro induction and isolation of antigen-specific T cells from the naïve repertoire. We demonstrate that the likelihood of successful generation of primary immune responses is determined by a delicate balance between the numbers of antigen-specific precursor T cells and the numbers and activation state of regulatory T cells locally at the site of priming of the immune response.

摘要

背景

同种异体干细胞移植的主要挑战之一是在移植物抗宿主病的有害诱导与移植物抗白血病和病原体特异性免疫反应的有益作用之间找到平衡。过继转移具有特定抗白血病或病原体特异性活性的体外生成供体 T 细胞可能是有效的。然而,在许多情况下,这需要从幼稚供体 T 细胞库中体外引发和扩增抗原特异性前体 T 细胞。

设计和方法

通过共培养 CD45RO 耗尽的、调节性 T 细胞耗尽的供体外周血单核细胞与自体肽负载的树突状细胞,然后用肽负载的自体单核细胞进行两次再刺激,生成抗原特异性 CD8 T 细胞。根据 CD137 表达分离反应性 T 细胞,并使用肽/主要组织相容性复合物四聚体进一步纯化。

结果

使用这种方法,我们能够从血清阴性、次要组织相容性抗原阴性供体的幼稚 T 细胞库中重复地产生针对多种病毒抗原和次要组织相容性抗原的功能高亲和力 T 细胞。此外,我们证明通过耗尽 CD45RO(+)应答细胞来减少调节性 T 细胞的频率可导致抗原特异性前体 T 细胞的更好引发和扩增。

结论

总之,我们提出了一种从幼稚库中体外诱导和分离抗原特异性 T 细胞的稳健方法。我们证明成功产生初级免疫反应的可能性取决于免疫反应引发部位的抗原特异性前体 T 细胞数量与调节性 T 细胞数量和激活状态之间的微妙平衡。